CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 
 

CBPO's Net Income Growth by Quarter and Year

China Biologic Products Holdings Inc 's Net Income results by quarter and year




CBPO Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 163.40 147.97 82.24 23.18
III Quarter September - - - 35.39
II Quarter June - - 34.84 37.49
I Quarter March - - 34.34 32.73
FY   163.40 147.97 151.42 128.79



CBPO Net Income forth quarter 2019 Y/Y Growth Comment
China Biologic Products Holdings Inc reported Net Income increase of 10.42% year on year in the forth quarter 2019, to $ 163.40 millions, this is lower than China Biologic Products Holdings Inc 's recent average Net Income improvement of 22.21%.

Looking into forth quarter 2019 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Net Income growth. While China Biologic Products Holdings Inc ' s Net Income growth of 10.42% ranks overall at the positon no. 748 in the forth quarter 2019.




CBPO Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December 10.42 % 79.92 % 254.79 % 14.02 %
III Quarter September - - - 18.44 %
II Quarter June - - -7.07 % 9.49 %
I Quarter March - - 4.92 % 10.35 %
FY   10.42 % -2.28 % 17.57 % 12.86 %

Financial Statements
China Biologic Products Holdings Inc 's forth quarter 2019 Net Income $ 163.40 millions CBPO's Income Statement
China Biologic Products Holdings Inc 's forth quarter 2018 Net Income $ 147.97 millions Quarterly CBPO's Income Statement
New: More CBPO's historic Net Income Growth >>


CBPO Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -34.5 %
III Quarter September - - - -5.6 %
II Quarter June - - 1.46 % 14.54 %
I Quarter March - - 48.14 % 60.99 %
FY (Year on Year)   10.42 % -2.28 % 17.57 % 12.86 %




Net Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #55
Overall #748

Net Income Y/Y Growth Statistics
High Average Low
254.77 % 22.21 % -2.04 %
(Dec 31 2017)   (Jun 30 2017)
Net Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #55
Overall #748
Net Income Y/Y Growth Statistics
High Average Low
254.77 % 22.21 % -2.04 %
(Dec 31 2017)   (Jun 30 2017)

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

China Biologic Products Holdings Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
115.08 % -2.8 % -100 %
(Mar 31 2013)  


CBPO's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
115.08 % -2.8 % -100 %
(Mar 31 2013)  


CBPO's IV. Quarter Q/Q Net Income Comment


China Biologic Products Holdings Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Net Income 12 Months Ending $ 163.40 $ 147.97 $ 82.24 $ 127.74 $ 130.40
Y / Y Net Income Growth (TTM) 10.43 % 79.93 % 254.77 % 6.07 % 11.28 %
Year on Year Net Income Growth Overall Ranking # 1018 # 0 # 0 # 0 # 523
Seqeuential Net Income Change (TTM) 10.43 % 79.93 % 254.77 % -2.04 % 1.25 %
Seq. Net Income Growth (TTM) Overall Ranking # 748 # 0 # 0 # 0 # 276




Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Dec 31 2019 period, China Biologic Products Holdings Inc 's cumulative twelve months Net Income were $ 163 millions, company would post below average annual Net Income growth of 1.25% year on year, if the fiscal year would end at Dec 31 2019.
A slow-down in the China Biologic Products Holdings Inc 's Net Income growth from the 0% growth in Dec 31 2018.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1018.

Net Income TTM Q/Q Growth Statistics
High Average Low
254.77 %
22.21 %
-2.04 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 82
Overall # 1018

Net Income TTM Y/Y Growth Statistics
High Average Low
254.77 %
34.15 %
6.07 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 55
S&P 500 # 748
Cumulative Net Income growth Comment
With the quarterly Net Income reported in the Dec 31 2019 period, China Biologic Products Holdings Inc 's cumulative twelve months Net Income were $ 163 millions, company would post below average annual Net Income growth of 6.07% year on year, if the fiscal year would end at Dec 31 2019.
A slow-down in the China Biologic Products Holdings Inc 's Net Income growth from the 0% growth in Dec 31 2018.

In the Healthcare sector 81 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 1018.

Net Income TTM Q/Q Growth Statistics
High Average Low
254.77 %
22.21 %
-2.04 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 82
Overall # 1018

Net Income TTM Y/Y Growth Statistics
High Average Low
254.77 %
34.15 %
6.07 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 55
S&P 500 # 748




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CBPO's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CBPO's Competitors
Net Income Growth for China Biologic Products Holdings Inc 's Suppliers
Net Income Growth for CBPO's Customers

You may also want to know
CBPO's Annual Growth Rates CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio
CBPO's Roa CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Comparisons



Companies with similar Net Income growth for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2019
Masimo Corp12.76%$ 12.756 millions
Zynex inc.12.40%$ 12.395 millions
Citrine Global Corp11.97%$ 11.972 millions
National Research Corporation11.50%$ 11.499 millions
China Biologic Products Holdings Inc 10.43%$ 10.427 millions
Biospecifics Technologies Corp9.25%$ 9.254 millions
Grifols Sa9.12%$ 9.125 millions
Redhill Biopharma Ltd 8.97%$ 8.975 millions
Intricon Corp6.82%$ 6.815 millions
Mettler Toledo International Inc6.38%$ 6.382 millions
Pro dex Inc.5.94%$ 5.937 millions
Purple Biotech Ltd 5.82%$ 5.818 millions
Idexx Laboratories Inc5.68%$ 5.681 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MDB's Profile

Stock Price

MDB's Financials

Business Description

Fundamentals

Charts & Quotes

MDB's News

Suppliers

MDB's Competitors

Customers & Markets

Economic Indicators

MDB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071